NeoGenomics Inc. Common Stock vs Seagate Technology Holdings PLC — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Seagate Technology Holdings PLC trades at $686.3 (market cap $162.25B). The key difference: Seagate Technology Holdings PLC is far larger — about 74.8× NeoGenomics Inc. Common Stock's market cap, and Seagate Technology Holdings PLC pays a 0.41% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Seagate Technology Holdings PLC for 41 Days on average.
| NEO | STX | |
|---|---|---|
Market Cap | $2.17B | $162.25B |
Volume | 1,615,943 | 4,208,805 |
Sector | Health | Technology |
52-Week High | $19.91 | $1.09K |
52-Week Low | $7.19 | $214.40 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $2.47B | $164.41B |
Dividend Yield | — | 0.41% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Seagate Technology (STX) trades at $746.86, down 0.85% amid recent sector pressure from Toshiba's AI storage expansion plans. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $5.71 vs. $5.10, continuing a trend of earnings outperformance. Technical indicators signal bearish momentum with the price near support at $746, while RSI levels suggest potential oversold conditions. Revenue recovery continues with 2025 reaching $9.10B and 2026 projected at $12.20B, driving improved profitability margins.
Despite near-term competitive headwinds, Seagate maintains strong analyst support with 55.77% buy ratings and $1,130 consensus price target representing 51% upside. The company's dominant position in AI data storage and robust 371.53% ROE support long-term growth prospects, though investors face risks from increased competition and volatile memory pricing cycles that could pressure margins.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →